Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 25, 2010 10:28 ET | Source: ATMI, Inc.

ATMI LifeSciences and Austar Announce Completion of Beijing Biopharmaceutical Manufacturing Facility

DANBURY, Conn., Oct. 25, 2010 (GLOBE NEWSWIRE) -- ATMI, Inc. (Nasdaq:ATMI) today announced that it has further extended its global biopharma manufacturing footprint with the opening of a new Chinese...
October 25, 2010 08:30 ET | Source: DARA BioSciences, Inc.

DARA BioSciences Signs Definitive Agreement to Raise $1.4 Million in Registered Direct Offering

RALEIGH, N.C., Oct. 25, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with...
October 25, 2010 07:00 ET | Source: Neptune Technologies & Bioresources Inc

Neptune Technologies & Bioressources Inc. Enters Pharmaceutical Market With Onemia(TM) Launch by Acasti Pharma Inc.

LAVAL, Quebec, Oct. 25, 2010 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX-V:NTB) enters the pharmaceutical market with the launch of...
October 25, 2010 07:00 ET | Source: Agenus Inc.

Antigenics Announces Expansion of Phase 2 Trial in Glioma

LEXINGTON, Mass., Oct. 25, 2010 (GLOBE NEWSWIRE) -- Antigenics, Inc. (Nasdaq:AGEN) today announced the expansion of a phase 2 clinical study of HSPPC-96 (Oncophage® vaccine; vitespen),...
October 25, 2010 02:32 ET | Source: EQS Group AG

DGAP-News: Viridax collaborates with Slovenian partner on novel antimicrobials

Viridax Corporation / Key word(s): Alliance/Miscellaneous 25.10.2010 08:32 --------------------------------------------------------------------------- October 25, 2010 - Viridax Corporation...
October 25, 2010 01:15 ET | Source: Novartis Pharma AG

Phase III data show that Novartis meningococcal vaccine Menveo® demonstrated robust immunogenicity in infants

New pivotal phase III data show Menveo induced immune responses in a high percentage of infants against four important meningococcal disease-causing serogroups[1] The highest rates of meningococcal...
October 24, 2010 05:30 ET | Source: Better Health Publishing

A Closer Look at Herbal Formulas Versus Pharmaceuticals

SANTA ROSA, Calif., Oct. 24, 2010 (GLOBE NEWSWIRE) -- We hear more and more of multiple pharmaceutical drugs either being pulled off the market or receiving warnings from the FDA. From Avendia for...
October 23, 2010 02:30 ET | Source: RabbitClone.com

RabbitClone Identifies Healthy Fresh Organic Acai Berry Vending Scam

SAN FRANCISCO, Oct. 23, 2010 (GLOBE NEWSWIRE) -- RabbitClone.com, a website duplication service that helps consumers avoid costly financial pitfalls, has announced identification of a fresh scam...
October 22, 2010 07:12 ET | Source: AstraZeneca PLC

Europeiska läkemedelsmyndigheten ger stöd för vaccinet Fluenz nässpray, vid förebyggande av säsongsinfluensa hos barn

Europeiska läkemedelsmyndigheten ger stöd för vaccinet Fluenz nässpray, vid förebyggande av säsongsinfluensa hos barn EMA:s vetenskapliga kommitté CHMP (Committee for Medicinal Products for Human...
October 21, 2010 16:00 ET | Source: Align Technology, Inc.

Align Technology Announces Memorandum of Understanding for Settlement of Proficiency Requirements Lawsuit

SAN JOSE, Calif., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced that it has entered into a Memorandum of Understanding ("MOU") to resolve a class action...
October 21, 2010 16:00 ET | Source: Align Technology, Inc.

Align Technology Receives Regulatory Approval to Market and Sell Invisalign in China

SAN JOSE, Calif., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced that it has received regulatory approval from the Chinese State Food and Drug Administration...
October 21, 2010 16:00 ET | Source: Align Technology, Inc.

Align Technology Announces Third Quarter Fiscal 2010 Results

Q3 revenues of $95.9 million increased 21.0% year-over-year Q3 Invisalign case shipments of 66.2 thousand increased 17.2% year-over-year Q3 gross margin of 78.1% increased 3.7% points...
October 21, 2010 14:51 ET | Source: Competitive Technologies, Inc.

Competitive Technologies Announces New Contract to Distribute the Calmare(R) Pain Therapy Medical Device in the Middle East

FAIRFIELD, Conn., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) announced today that on Monday, October 18, 2010, its Geneva, Switzerland-based distributor, Life...
October 21, 2010 12:00 ET | Source: Herborium Group, Inc.

Herborium Engages Investor and Media Relations

SADDLE BROOK, N.J., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Herborium Group, Inc., (Pink Sheets:HBRM) www.herborium.com, a Botanical Therapeutics™ company, today announced it has retained SmallCap...
October 21, 2010 10:00 ET | Source: inVentiv Health, Inc.

inVentiv Health Agencies Win Big at MM&M Awards

SOMERSET, N.J., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Four companies within inVentiv Health were recognized with top honors at the 2010 Medical Marketing & Media Awards, held in New York City on...
October 21, 2010 10:00 ET | Source: Nasdaq, Inc.

Intellipharmaceutics International Inc. (IPCI) Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell

ADVISORY, Oct. 21, 2010 (GLOBE NEWSWIRE) -- What: Intellipharmaceutics International Inc. (IPCI) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the occasion,...
October 21, 2010 09:30 ET | Source: MusclePharm

Former FDA Research Chemist, Ron Sekura B.S., M.S., PhD., Joins MusclePharm Board of Directors

DENVER, Oct. 21, 2010 (GLOBE NEWSWIRE) -- MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement company with a proprietary formulation used in its portfolio of...
October 21, 2010 09:00 ET | Source: Dynavax Technologies

Dynavax to Host Analyst & Investor Day Webcast October 29, 2010

BERKELEY, CA--(Marketwire - October 21, 2010) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will webcast its first Analyst & Investor Day on Friday, October 29,...
October 21, 2010 08:30 ET | Source: CAS Medical Systems, Inc.

CASMED Announces 9 Scientific Abstracts Demonstrating the Benefits of FORE-SIGHT Absolute Oximetry

BRANFORD, Conn., Oct. 21, 2010 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today announced that nine new scientific abstracts demonstrating the use of the Company's FORE-SIGHT®...
October 21, 2010 07:04 ET | Source: Genmab A/S

Nettoomsætning for arzerra i tredje kvartal 2010

- Nettoomsætningen for Arzerra for tredje kvartal 2010 var på ca. DKK 78 mio. med en forventet royalty til Genmab på ca. DKK 15,6 mio. København, Danmark, 21. oktober 2010...
October 21, 2010 07:04 ET | Source: Genmab A/S

Arzerra Third Quarter 2010 Net Sales Figures

- Net sales of Arzerra for the third quarter of 2010 were approximately DKK 78 million, with an expected royalty payment to Genmab of approximately DKK 15.6 million. ...
October 21, 2010 06:50 ET | Source: MicroStockProfit.com

VIVUS Inc. is Today's Focus Stock on MicroStockProfit.com

DALLAS, Oct. 21, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring VIVUS Inc. (Nasdaq:VVUS). The report includes financial, comparative and investment analyses,...
October 21, 2010 02:00 ET | Source: Helix BioPharma Corp.

Helix BioPharma Corp. Reports Positive Efficacy and Safety Findings From Phase II Study of Its Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions

AURORA, ON--(Marketwire - October 21, 2010) - Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and...
October 21, 2010 01:00 ET | Source: Novartis Pharma AG

Novartis réalise une excellente performance au troisième trimestre: les produits lancés récemment génèrent 20%* du chiffre d'affaires, homologation de Gilenya, consolidation d'Alcon

Chiffres-clés: troisième trimestre et neuf mois au 30 septembre ...
October 21, 2010 01:00 ET | Source: Novartis Pharma AG

Novartis delivers excellent performance in third quarter: recently launched products generate 20%* of sales; Gilenya approved; Alcon consolidated

Key figures - third quarter and nine months to September 30 ...
October 21, 2010 01:00 ET | Source: Novartis Pharma AG

Novartis erzielt im dritten Quartal eine hervorragende Performance: Die jüngsten Produkte steuern 20%* zum Umsatz bei; Gilenya wird zugelassen; Alcon wird konsolidiert

Kennzahlen - drittes Quartal und neun Monate bis 30. September 3. Quartal...
October 20, 2010 08:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Submits Special Protocol Assessment to FDA for Its Phase 3 CLI Program

ANN ARBOR, Mich., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular...
October 20, 2010 08:30 ET | Source: PositiveID Corporation

PositiveID Corporation Receives Initial Order for 15,000 iGlucose Units From Liberator Medical Holdings, Inc.

DELRAY BEACH, Fla., Oct. 20, 2010 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (Nasdaq:PSID) announced today that it has received an initial order of 15,000...
October 20, 2010 08:15 ET | Source: Cytomedix, Inc.

Cytomedix to Showcase AutoloGel System at the 18th Annual Scientific Meeting of the International Society of Hair Restoration Surgery

GAITHERSBURG, Md., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
October 20, 2010 07:30 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Design of Phase III Iron Therapy Program for SFP

WIXOM, Mich., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease...
October 20, 2010 02:00 ET | Source: Photocure ASA

Photocure signs agreement with Salix Pharmaceuticals for Lumacan(TM)

Oslo, Norway, 20 October, 2010; Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused in dermatology and cancer, announced today it has signed a strategic global agreement...
October 19, 2010 18:21 ET | Source: MAKO Surgical Corp.

MAKO Surgical Corp. Schedules Third Quarter 2010 Earnings Release and Conference Call for Tuesday, November 2, 2010

FT. LAUDERDALE, Fla., Oct. 19, 2010 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release third quarter 2010 financial results after market close on Tuesday,...
October 19, 2010 17:00 ET | Source: MediciNova, Inc.

MediciNova's MN-166 Program Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch

SAN DIEGO, Oct. 19, 2010 (GLOBE NEWSWIRE) -- MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities...
October 19, 2010 16:32 ET | Source: Avantis Medical Systems

New Study Shows That the Third Eye(R) Retroscope(R) Improves Adenoma Detection by More Than 23 Percent Compared to Standard Colonoscopy

SAN ANTONIO, TX--(Marketwire - October 19, 2010) - Avantis Medical Systems, Inc., a technology leader in developing novel catheter-mounted digital imaging devices, today announced three new...
October 19, 2010 09:30 ET | Source: Adamis Pharmaceuticals Corporation

Adamis Completes Acquisition of Prostate Drug Candidates

SAN DIEGO, Oct. 19, 2010 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (OTCBB:ADMP), today announced the completion of the acquisition from Colby Pharmaceuticals of the remaining exclusive...
October 19, 2010 09:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Receives Notice of Patent Allowance From China for CBLB502

BUFFALO, NY--(Marketwire - October 19, 2010) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced today that it has received a notice of grant of patent for CBLB502 from the State Intellectual...
October 19, 2010 08:54 ET | Source: Herborium Group, Inc.

Herborium Group Completes OTC Markets' Information Compliance

SADDLE BROOK, N.J., Oct. 19, 2010 (GLOBE NEWSWIRE) -- Herborium Group, Inc., (Pink Sheets:HBRM) www.herborium.com, a Botanical Therapeutics™ company, today announced it has filed all Pink...
October 19, 2010 08:00 ET | Source: TearLab Corporation

CPT Code for TearLab Osmolarity Test Published by the American Medical Association

SAN DIEGO, Oct. 19, 2010 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) announced today that, further to its press release of October 8, 2010, a unique new Current Procedural...
October 19, 2010 07:30 ET | Source: MELA Sciences

MELA Sciences Announces MelaFind(R) Pivotal Data Published in Online Edition of Archives of Dermatology

IRVINGTON, NY--(Marketwire - October 19, 2010) - MELA Sciences, Inc. (NASDAQ: MELA) today announced that the results of the company's MelaFind® pivotal trial and pilot reader study have...
October 19, 2010 06:50 ET | Source: MicroStockProfit.com

Cell Therapeutics Inc. is Today's Focus Stock on MicroStockProfit.com

DALLAS, Oct. 19, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. (Nasdaq:CTIC). The report includes financial, comparative and investment...
October 19, 2010 02:05 ET | Source: Helix BioPharma Corp.

Helix BioPharma Corp. Retains CFSG1 as Its Exclusive U.S. Investor Relations Firm

AURORA, ON--(Marketwire - October 19, 2010) - Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a biopharmaceutical company focused on cancer therapy, today announced that it...
October 19, 2010 02:00 ET | Source: mdxhealth

MDxHealth définit une nouvelle stratégie

Concentration sur les tests de diagnostic moléculaire pour une médecine personnalisée en oncologieDURHAM, NC, et LIEGE, BELGIQUE - le 19 Octobre 2010 - MDxHealth (NYSE Euronext: MDXH), un leader du...
October 19, 2010 02:00 ET | Source: mdxhealth

MDxHealth Outlines New Strategy

Focus on molecular diagnostic testing for personalized medicine in oncology DURHAM, NC, and LIEGE, BELGIUM - October 19, 2010 - MDxHealth (NYSE Euronext: MDXH), a leading molecular diagnostics...
October 19, 2010 02:00 ET | Source: Helix BioPharma Corp.

Helix BioPharma Corp. Files IND for Its Planned Phase II/III Efficacy Trial of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions

AURORA, ON--(Marketwire - October 19, 2010) - Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a developer of biopharmaceutical product candidates for the prevention and...
October 19, 2010 01:46 ET | Source: Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB announces a fully committed and underwritten rights issue

PRESS RELEASE October 19, 2010 Oasmia Pharmaceutical AB announces a fully committed and underwritten rights issue of SEK 239 million ...
October 19, 2010 01:46 ET | Source: Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB genomför en fullt garanterad företrädesemission

PRESSMEDDELANDE 19 oktober 2010 Oasmia Pharmaceutical AB genomför en fullt garanterad företrädesemission av aktier om 239 miljoner SEK ...
October 18, 2010 17:00 ET | Source: Pomerantz LLP

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Arena Pharmaceuticals, Inc.

NEW YORK, Oct. 18, 2010 (GLOBE NEWSWIRE) -- Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Arena Pharmaceuticals, Inc. ("Arena" or the "Company")...
October 18, 2010 09:00 ET | Source: Given Imaging

Given Imaging Launches New Products to Expand Access to PillCam(R) Capsule Endoscopy at ACG Annual Meeting 2010

SAN ANTONIO, TX--(Marketwire - October 18, 2010) - Given Imaging Ltd. (NASDAQ: GIVN), the world leader in specialty GI products and pioneer of capsule endoscopy, today unveiled two new products:...
October 18, 2010 08:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Receives FDA Fast Track Designation for Phase 3 CLI Program

ANN ARBOR, Mich., Oct. 18, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular...
October 18, 2010 08:00 ET | Source: XOMA Royalty Corporation

XOMA Announces Presentation and Webcast at NewsMakers in the Biotech Industry Conference

BERKELEY, Calif., Oct. 18, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced that Steven B. Engle, XOMA Chairman...